{
    "nctId": "NCT02597868",
    "briefTitle": "A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)",
    "officialTitle": "A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 132,
    "primaryOutcomeMeasure": "Progression-free survival(PFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent\n* The age is Above 18 years of age, \\<70 years old\n* HR-positive \\& HER2-negative\n* Metastatic breast cancer,incurable.\n* No prior chemotherapy for metastatic recurrence, if there is disease progression within 6 months after the end of the adjuvant chemotherapy, adjuvant chemotherapy as first-line treatment for metastatic lesions\n* Eastern Cooperative Oncology Group performance status (ECOG PS)=0\\~1\n* The basic function of normal bone marrow\n* Functions of liver and kidney is normal\n* Expectation of life is more than 3 months\n* Agreed to take contraceptive measures during treatment\n\nExclusion Criteria:\n\n* Previous toxicity was not recovered to 0-1 degrees\n* Central nervous system metastasis\n* Pregnancy or lactation\n* There are uncontrolled infection, myocardial infarction, thrombosis, etc.\n* There are uncontrolled chronic diseases such as diabetes, hypertension, peptic ulcer, chronic hepatitis, mental disease;\n* Researchers believe that is not suitable for the study\n* Patients with other malignant tumor history, except the healed skin basal cell carcinoma and carcinoma of uterine cervix;\n* Bilateral breast cancer",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}